Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
09/29/2005 | US20050214937 Surface proteins of leptospira |
09/29/2005 | US20050214922 Alkaline protease |
09/29/2005 | US20050214921 BGL3 beta-glucosidase and nucleic acids encoding the same |
09/29/2005 | US20050214920 Detergent composition containing the polypeptide and a surfactant; can be used in the conversion of cellulosic materials to monosaccharides, disaccharides, and polysaccharides |
09/29/2005 | US20050214919 Novel lipase genes |
09/29/2005 | US20050214918 Novel purified polypeptides from streptococcus pneumoniae |
09/29/2005 | US20050214917 Thermo-stable lactate oxidase |
09/29/2005 | US20050214915 Method of controlling ethanol production and mass production of lactic acid and transformant therefor |
09/29/2005 | US20050214912 Using transgenic escherichia, comprising hydantoinase and carbamoylase genes, as bioreactor for fermentation of histidine for use in foods and drugs |
09/29/2005 | US20050214908 Regulation of human transketolase-like enzyme |
09/29/2005 | US20050214904 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
09/29/2005 | US20050214901 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
09/29/2005 | US20050214899 Capable of removing the N-terminal Met from bulky or acidic penultimate residues |
09/29/2005 | US20050214896 Method for synthesis of aryl-carotenoids |
09/29/2005 | US20050214893 Identifying modulators for prevention and treatment of cell proliferative disorders; antitumor agents |
09/29/2005 | US20050214884 Method for stabilizing cholesterol dehydrogenase, cholesterol dehydrogenase-containing composition and cholesterol measuring reagent |
09/29/2005 | US20050214883 Novel alanine transaminase enzyme and methods of use |
09/29/2005 | US20050214879 Novel ubiquitin ligases as therapeutic targets |
09/29/2005 | US20050214858 Nucleotide sequences coding liver protein for identifying modulators for prevention and treatment diabetes |
09/29/2005 | US20050214852 Peptides for the treatment and diagnosis of systemic lupus erythematosus |
09/29/2005 | US20050214851 Linearized vector for heterologus gene transfer, control and expression |
09/29/2005 | US20050214846 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/29/2005 | US20050214844 Nucleotide sequences coding translocation protein for use in identifying modulators for prevention and treatment of cell proliferative ,inflammatory and autoimmune disorders |
09/29/2005 | US20050214839 Nuclease inhibitors and methods for their use |
09/29/2005 | US20050214822 Using cypin in assays, diagnostics and treatment of cognitive disorders |
09/29/2005 | US20050214819 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/29/2005 | US20050214818 Using cells expressing armitage (ARMI) polypetide as models for id entifying modulators of cell proliferative disorders |
09/29/2005 | US20050214817 Proteases from gram-positive organisms |
09/29/2005 | US20050214816 Expression vector comprising nucleotide sequences coding serine protease for use as proteolytic agent in cleaning products |
09/29/2005 | US20050214808 Plant having tolerance to environmental stress |
09/29/2005 | US20050214804 Novel human metalloprotease and polynucleotides encoding the same |
09/29/2005 | US20050214802 screening inhibitors of caspase interaction with a melanoma-inhibitor of apoptosis (ML-IAP) chimera; diagnosing cancer |
09/29/2005 | US20050214786 26 human secreted proteins |
09/29/2005 | US20050214785 Nucleotide sequences coding polypeptides; DNAs encoding such dendritic cell transmembrane serine proteases, and pharmaceutical and/or diagnostic compositions made therefrom, are disclosed; serine protease activity |
09/29/2005 | US20050214783 Novel human proteases and polynucleotides encoding the same |
09/29/2005 | US20050214776 Photoprotein capable of binding coelenterazine and molecular oxygen, allows for emission of light at longer wavelengths as result of energy transfer; assay for screening HIV-1 protease inhibitors; microanalysis and drug discovery; kits |
09/29/2005 | US20050214774 Isolated monkey cathepsin S proteins, nucleic acid molecules encoding monkey cathepsin S proteins, and uses thereof |
09/29/2005 | US20050214773 Recombinant UDP-N-acetylmuramoylalanine-D-glutamate ligase for use as tool in identifying modulators which prevent microbial infection; bactericides |
09/29/2005 | US20050214768 Regulation of human serine/threonine kinase |
09/29/2005 | US20050214766 genetic engineered nucleotide sequences that code polypeptides used as biosensors for measurement of glucose using enzyme electrodes |
09/29/2005 | US20050214761 For introducing DNA into organisms which produce large amounts of oils and, in particular, oils with a high content of unsaturated fatty acids |
09/29/2005 | US20050214755 Map kinase integrin-binding domain |
09/29/2005 | US20050214753 Detection of nucleic acid hybrids |
09/29/2005 | US20050214741 Method for formulating and immobilizing a matrix protein and a matrix protein for use in a sensor |
09/29/2005 | US20050214410 Modified xylanases exhibiting improved expression |
09/29/2005 | US20050214320 Mycobacterium vaccae; enhancement of immune Th1 or Th2 responses to heterologous antigens; tuberculosis, autoimmune thyroiditis, insulin-dependent diabetes mellitus, multiple sclerosis, Crohn's disease, peptic ulcers, organ transplant rejection, sarcoidosis, asthma, allergic rhinitis, cancer, lupus |
09/29/2005 | US20050214310 Drug delivery of an antibody-enzyme conjugate of an antibody (monoclonal antibody L49) reactive with an antigen on the surface of tumor cells conjugated to an enzyme ( beta-lactamase) that converts a nitrogen mustard-type prodrug into the more cytotoxic parent drug |
09/29/2005 | US20050214306 Surface proteins of leptospira |
09/29/2005 | US20050214295 Combined chemotherapy compositions and methods for the treatment of cancer, ischemia-reperfusion injury, and septic shock |
09/29/2005 | US20050214276 Delta 4, 5 glycuronidase and uses thereof |
09/29/2005 | US20050214264 Engineered to include recombinant lytic factor; evades host immune system; high capacity, target cell specificity; genes and nonnucleic acid materials |
09/29/2005 | US20050214258 Vectors for delivering viral and oncogenic inhibitors |
09/29/2005 | DE102004062386A1 Monacolin K-Biosynthese-Gene Monacolin K biosynthesis genes |
09/29/2005 | DE102004012481A1 Using uridine monophosphate synthase as target for identifying herbicides and plant growth regulators, also the identified compounds and transgenic plants resistant to them |
09/29/2005 | CA2795418A1 Improved bacterial host cell for the direct expression of peptides |
09/29/2005 | CA2560259A1 Methods for increasing protein polyethylene glycol (peg) conjugation |
09/29/2005 | CA2560247A1 Thrombin derivative and pharmaceutical composition containing the same |
09/29/2005 | CA2559840A1 Prostatic acid phosphatase antigens |
09/29/2005 | CA2559720A1 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
09/29/2005 | CA2559586A1 Methods and compositions involving s-ship promoter regions |
09/29/2005 | CA2559361A1 Expression of nitrile hydratases in a two-vector expression system |
09/29/2005 | CA2559235A1 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof and therapeutic uses thereof |
09/29/2005 | CA2559211A1 Detection, isolation and uses of renalase (monoamine oxidase c) |
09/29/2005 | CA2558635A1 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
09/29/2005 | CA2558372A1 Improved constructs for marker excision based on dual-function selection marker |
09/29/2005 | CA2557476A1 Nitrile hydratases from metagenome libraries |
09/29/2005 | CA2557295A1 Improved bacterial host cell for the direct expression of peptides |
09/29/2005 | CA2555109A1 Methods of refolding mammalian glycosyltransferases |
09/29/2005 | CA2537110A1 Wave energy converter (wec) with magnetic braking |
09/29/2005 | CA2536603A1 Wave energy converters (wecs) with linear electric generators (legs) |
09/28/2005 | EP1580282A1 Use of human RPS6KA6-related gene variant for diagnosing T cell lymphoblastic lymphoma |
09/28/2005 | EP1580270A1 Gene for increasing crop yield and use thereof |
09/28/2005 | EP1580268A1 Mutant d-aminotransferase and process for producing optically active glutamic acid derivative using the same |
09/28/2005 | EP1580267A1 Gene improving temperature-tolerance of acetic acid bacterium, acetic acid bacterium bred using the gene and process for producing vinegar using the acetic acid bacterium |
09/28/2005 | EP1579871A1 Vascular endothelial cell growth factor antagonists and uses thereof |
09/28/2005 | EP1579186A2 Identification of kinase inhibitors |
09/28/2005 | EP1579011A2 Modulation of death-associated protein kinase 1 expression |
09/28/2005 | EP1579001A2 Materials and methods for prevention and treatment of rna viral diseases |
09/28/2005 | EP1578997A2 Nucleic acids encoding ranpirnase variants and methods of making them |
09/28/2005 | EP1578991A2 Methods of diagnosing & treating diabetes and insulin resistance |
09/28/2005 | EP1578989A2 Novel nucleic acids and secreted polypeptides |
09/28/2005 | EP1578987A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
09/28/2005 | EP1578975A2 Method for producing aminoacids |
09/28/2005 | EP1578973A1 Plant cells and plants which synthesize a starch with an increased final viscosity |
09/28/2005 | EP1578964A2 Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same |
09/28/2005 | EP1578963A2 Galactanase variants |
09/28/2005 | EP1578962A2 Carrier-ligand fusions and uses thereof |
09/28/2005 | EP1578961A2 Bindingzyme arrays and high-throughput proteomic methods |
09/28/2005 | EP1578955A2 Candida kefyr cytosine deaminase |
09/28/2005 | EP1578953A2 Process for the determination of the primary structure of the messenger rna coding for the human recombinant endooligopeptidase a (heopa) [af217798]... |
09/28/2005 | EP1578951A2 Dna polymerases with reduced base analog detection activity |
09/28/2005 | EP1578949A2 Site specific incorporation of keto amino acids into proteins |
09/28/2005 | EP1578946A2 Utilization of starch products for biological production by fermentation |
09/28/2005 | EP1578943A2 NOVEL VARIANT i HYPROCREA JECORINA /i CBH1 CELLULASES |
09/28/2005 | EP1578941A2 Csnks as modifiers of the rac pathway and methods of use |
09/28/2005 | EP1578938A2 Promotion of peroxisomal catalase function in cells |
09/28/2005 | EP1578937A2 Xylose isomerases, nucleic acids encoding them and methods for making and using them |
09/28/2005 | EP1578935A2 Proteases, nucleic acids encoding them and methods for making and using them |
09/28/2005 | EP1578932A2 Synthetic tag genes |
09/28/2005 | EP1578931A2 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase |